| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash and restricted cash provided by (used in) financing activities | 57,112 | 98,927 |
| Effect of exchange rate on cash and cash equivalents and restricted cash | -261 | -60 |
| Net decrease in cash and cash equivalents and restricted cash | -35,492 | -526 |
| Cash and cash equivalents at beginning of period | 178,496 | - |
| Cash and cash equivalents at end of period | 143,004 | - |
Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH)